SAINT PETERSBURG, Russia--(BUSINESS WIRE)--The trastuzumab biosimilar, to be marketed under the trade name HERtiCAD™, is the first trastuzumab biosimilar to receive authorization from the Russian ...
Russian biotech Biocad said it reached a deal with Sothema Labs of Morocco to produce biosimilars rituximab and bevacizumab, used to treat cancer. The St. Petersburg-based company said the drugs, ...
The biotechnology company BIOCAD has signed an agreement with the State Scientific Center for Virology and Biotechnology «Vektor» (Novosibirsk) on joint work on a vaccine based on rVSV against ...
Roche has once again escaped a lawsuit claiming it went to illegal lengths to block biosimilars to its top-selling cancer meds. Russia’s Biocad sued Roche in 2016, claiming the Swiss drugmaker ...
Add Yahoo as a preferred source to see more of our stories on Google. A logo of BIOCAD company is seen on a door at the company's production facility in Saint Petersburg MOSCOW (Reuters) - Biotech ...
SAINT PETERSBURG, Russia--(BUSINESS WIRE)--Russian biotechnology company BIOCAD and Moroccan pharmaceutical company Sothema Labs announced the launch of medicines derived using the technology provided ...
Netakimab is a humanized anti-interleukin 17A antibody approved for the treatment of moderate-to-severe plaque psoriasis. Phase three clinical trial PATERA evaluated the effects of netakimab on signs ...
The international pharmaceutical trade fair CPhI Worldwide held October 9-11, 2018 in Madrid (Spain), lays a solid cornerstone of the growth in exports. SAINT PETERSBURG, Russia-- (BUSINESS ...
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated ...
St. Petersburg, March 29 : BIOCAD biotechnology company was granted access to supply highly demanded medicine - rituximab biosimilar to Vietnam for a second time. It imples that BIOCAD partners will ...
Biocad, a Russian biotechnology company that’s trying to copy some of the world’s top-selling cancer medicines, is seeking a buyer, said two people with direct knowledge of the matter. Biocad may be ...
MOSCOW (Reuters) - Biotech group Biocad is discussing producing in China a potential COVID-19 vaccine being developed by Russia's Vector state virology institute, the director of the St ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results